Acceleron Pharma, Inc. is developing drugs that regulate tissue size and function based on the Growth and Differentiation Factors (GDF) family of molecules. GDFs are potent, naturally occurring molecules that play a key role in the growth and repair of various tissues. Acceleron is developing therapies based on GDF biology to target diseases that affect bone, muscle, vasculature, and fat.
The company’s IP estate includes over 100 patents covering most of the GDF receptors. The company has a major development deal with Celgene for all bone growth indications. Under the terms of this deal, Celgene is covering a significant percentage of development costs, plus substantial milestone payments, significant royalties and North American co-marketing rights.
Air Computing, Inc. is an early stage company based in Palo Alto, CA allowing enterprise customers to synch and share all data securely behind a firewall with unlimited storage called AeroFS. AeroFS is positioning to be the synch and share vendor for the enterprise. They incorporate peer-to-peer networking and encrypted security completely behind the firewall for their enterprise customers.
Afraxis is discovering and developing drugs to treat diseases through the modulation of p21-activated kinase (PAK). Afraxis’ initial indication of interest is Fragile X syndrome with future expansion into other CNS diseases, including schizophrenia and autism spectrum disorders. By inhibiting PAK, a protein that regulates the development and maturation of synaptic connections that are defective in mental retardation syndromes and other CNS diseases, Afraxis will target CNS disease modification rather than just treat symptoms. PAK is also implicated in a number of different oncological settings and Afraxis is exploring the potential of PAK inhibitors for the treatment of cancers such as neurofibromatosis, breast cancer and lung cancer.
Ambit Biosciences, Inc. is engaged in the discovery and development of small-molecule kinase inhibitors for the treatment of cancer.
Ambit’s lead product candidate, AC220, is an oral, small molecule FMS-like tyrosine kinase-3 (FLT3) inhibitor being developed for the treatment of Acute Myeloid Leukemia (AML), the most common type of blood cancer in adults. FLT3 is mutated and activated in 25-40% of AML patients, causing poor prognosis and decreased response to existing treatments including chemotherapy and stem cell treatments. AC220 has entered a Phase 2 pivotal trial after obtaining concurrence from the FDA for its co-primary endpoint as a single, open-label trial which may be eligible to support registration (marketing approval), depending on the results it will generate. Called the ACE trial (AC220 monotherapy Efficacy study), this clinical trial will enroll a total of 180 patients who have refractory or relapsed AML with a mutated FLT3 kinase called internal tandem duplication (FLT3-ITD), which has negative prognostic implications.
Ambit’s second clinical candidate, AC480, is a pan-HER (human epidermal growth factor receptor) small molecule tyrosine kinase inhibitor; HER kinases (e.g., HER-1 or EGFR, HER-2, HER-3, HER-4) and the attendant signaling transduction pathway have been found to correlate with, and contribute to, a variety of human malignancies, including breast, gastric, lung, head and neck, and colorectal cancer. AC480, licensed from Bristol-Myers Squibb, has shown unique and promising results in pre-clinical animal cancer and human xenograft model (e.g., synergistic effects with paclitaxel, another widely-used chemotherapeutic drug), including the ability to cross the blood-brain barrier, a characteristic that would be useful in the treatment of brain tumors and metastases.
Founded in 2005, AnaptysBio, Inc. is a privately-held company focused on the generation of antibody therapeutics, and the leader in the use of somatic hypermutation (SHM) for antibody discovery and optimization. SHM is the body’s natural process for generating potent antibodies. AnaptysBio’s proprietary SHM-XEL platform, which couples fully human antibody libraries with in vitro somatic hypermutation (SHM) in mammalian cells to generate high affinity lead candidates, replicates key features of the human immune system and overcomes limitations of prior antibody technologies. By harnessing the natural mechanism of antibody maturation under controlled conditions, SHM-XEL allows for the selection of optimal antibody properties such as high affinity, functionality, cross-reactivity and epitope diversity. AnaptysBio has established broad intellectual property around the use of SHM and is currently building a pipeline of novel therapeutic antibody product candidates. The Company has signed partnerships with Merck, Roche, Novartis, Celgene, Gilead and DARPA. Major investors in AnaptysBio include founding investor Avalon Ventures, as well as Alloy Ventures, Frazier Healthcare Ventures, and Novo A/S.
Aratana Therapeutics, Inc., based in Kansas City, is a companion-animal health company, leveraging human pharmaceutical and biotechnology drug development to identify compounds that can be developed into novel therapeutics for dogs and cats. Companion animal health provides numerous market advantages over human health. Animal health drug development poses unique regulatory challenges, but with the experienced Aratana drug development team, and their ability to pick the right compounds at the right stage, new medicines can be developed in significant less time and in a very cost efficient manner, compared to human drug development. Another significant advantage is that in veterinary medicine, there are no third party payer issues, and pet owners are eager to purchase state of the art medicines for their pets, who are increasingly viewed as family members. In addition, there are 10 multi-billion-dollar companies that provide therapeutics to companion animals and fewer than a dozen biotechs servicing this group (compared to 20 big pharmas and 2000+ biotechs). The focus is on developing drugs for major diseases and unmet needs for companion animals, using a capital efficient drug development model to streamline the path to regulatory approval. By identifying molecules with specific attributes, compounds can be developed in a cost-effective and expedited timeline.
Avelas Biosciences, Inc. is advancing a new, improved way of cancer surgery called fluorescence-image guided surgery (FIGS). Avelas’ mission is to pioneer a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons leading to improved surgical results and better outcome for patients. The technology platform, called activatable cell penetrating peptide (ACPP), was invented by Prof. Roger Y. Tsien, the 2008 Nobel Laureate in Chemistry.
Specifically, the Avelas Cancer Illuminator™ (ACI) targets cancers via activation by pathologic enzymes used by a wide-variety of cancers to invade and metastasize. Avelas has created new proprietary versions more optimal for human application and is focused on advancing a lead ACI into human clinical trials along with companion FIGS visualization system designed to easily fit into the existing practice of oncologic surgery.
Avelas’ lead ACI program is focused on detecting metastatic breast cancer where it could enable real-time visualization of lymph node metastases, significantly improving surgical staging and decreasing the need for reoperations.
Awarepoint is the leader in providing workflow automation and tracking solutions to the acute care hospital marketplace. Real-Time Location System (RTLS) solutions have quickly become must-have tools for hospitals tackling asset management, compliance, and efficient patient throughput challenges. Ever increasing numbers of advanced healthcare provider organizations are turning to Awarepoint and the Company’s software and technology platform solution as their RTLS-enabled workflow automation provider of choice.
Backupify is the leading backup provider for cloud application data, offering an all-in-one archiving, search and restore solution for the most popular online services including Google Apps, Salesforce, Facebook, Twitter and more. Backupify ensures that companies can access and control the data they entrust to these systems and prevents data loss from external threats, user error or service failure. Backupify was founded in 2008 and is based in Cambridge, Massachusetts.
Bagooba’s mission is to tap into the world’s emotional energy to empower humanity. It’s two products are WeChi, a commercial and enterprise product which features a patent pending technology for capturing and influencing the emotions of individuals and groups in a dynamic manner; and GoodChi which lets people use their social media activity for good anywhere on the web.
On Byliner.com, readers can discover, share, and discuss stories with a community of fellow readers, receive personalized recommendations, and follow their favorite writers. Byliner.com also acts as a platform for writers, enabling them to connect directly with their audience.
Cambrios Technologies Corporation is an advanced electronic nanomaterials company serving the consumer electronics and cleantech industries. The Company’s first product is ClearOhm™ coating material that makes use of inexpensive manufacturing methods to produce a transparent electrode, an essential component of displays, touch screens, thin film photovoltaics, and solid state lighting.
ClearOhm™ material will bring enhanced performance at a lower cost than the industry standard. Cambrios has evolved into a manufacturer of coating materials that can be sold directly to customers as well as through significant channels in Asia and the U.S. for their use in producing coated plastic film products. This is an important distinction as the margins in the coating material business are higher.
Consumer electronic devices sold by significant Asian companies that contain ClearOhm™ electrode layers began appearing in early 2011 and Cambrios has developed a steady pipeline of consumer electronic design wins with some of the most important companies in the world, many of which have become Cambrios investors.
Cardeas Pharma, specializes in early phase development of inhaled antibiotics to treat serious, hospital-acquired respiratory infections from highly antibiotic-resistant organisms. By combining novel formulations of proven antibiotics with cutting edge drug delivery technology Cardeas is addressing significant unmet medical needs in the critical-care setting.
Carolus Therapeutics, Inc. is a biopharmaceutical company developing new treatments for cardiovascular and inflammatory diseases. Carolus develops first-in-class peptide and antibody-based therapeutics for these indications. The Company continues to move its two preclinical programs toward human clinical trials. These programs remain: peptide antagonists and antibodies to MIF (the “MIF Program”); and disruption of the RANTES/PF4 heterodimerization, using its proprietary peptide, CT-2009 (the “CT-2009 Program”).
Chart.io is an early stage company based in San Francisco. Chart.io is a next generation business intelligence visualization software system for the enterprise delivered as a service. Chart.io makes sense of all the data you collect every day. Chart.io quickly hooks up to any SQL database and lets you create real-time charts of the metrics you care about as service over the web through your browser. We feel the company is extremely disruptive to the $3 billion business intelligence market in the enterprise.
Cheezburger is a social humor platform bringing internet culture and memes to the mainstream. Its collection of brands include I Can Has Cheezburger?, FAIL Blog, Memebase, Know Your Meme, and The Daily What. Cheezburger is building the first humor platform where everyone can share their sense of humor to make the world happy for 5 minutes a day.
Cloudant provides the world’s first globally distributed database-as-a-service (DBaaS) for loading, storing, analyzing, and distributing operational application data for developers of large and/or fast-growing Web and mobile applications. Cloudant’s DBaaS is a managed service that helps developers eliminate the delays, costs, and distractions inherent in working with databases and their administrators, while providing unmatched scalability, availability, and performance. This capability accelerates time-to-market and time-to-innovation because it frees developers from the mechanics of data management so they can focus exclusively on creating great applications. For more information, visitwww.cloudant.com.
Cloudkick provides award-winning cloud server monitoring and management tools, built from the ground up to support modern APIs and the elastic nature of the cloud. From performance monitoring and fault detection to trend visualization and graphing, their tools work across your entire cloud computing infrastructure, no matter what cloud provider you choose.
Cloudkick was acquired by Rackspace.
Connected Sports Ventures, Inc. is building a platform for 2nd screen applications focused on live sports. The company’s first app, RumbleTV Baseball, will be available exclusively on the iPad. The platform will extend to additional sports later this year and will also be available on the iPhone. Avalon participated in the company’s seed funding round.
E-Band Communications, Corp. designs and manufactures ultra-high performance multi-gigabit capacity wireless communication systems based upon 71-86 GHz millimeter-wave (aka “E-Band”) radio technology. EBCC uses highly integrated microwave monolithic integrated circuit technology that enables it to manufacture the highest performance wireless systems, which have a data rate of one Gbps to three Gbps over distances of several miles and availability up to 99%. EBCC solves last mile access bottleneck problems, connects enterprises to fiber networks, and enables backhaul of mobile (3G/4G) and fixed wireless (WiFi, WiMax) networks.
Figure 8 Wireless
Figure 8 Wireless developed “chip-level” software for wireless sensor networks using the ZigBee (802.15.4) wireless standard. Figure 8 was acquired by Chipcon of Norway which was then acquired by Texas Instruments Inc.
Good Technology develops and markets mobile security and control applications that allow organizations to connect and collaborate on their devices of choice. Good Technology allows enterprises, government agencies, and consumers to maximize personal and business productivity by providing secure and easy-to-use instant mobile access to data, applications and services on hundreds of mobile devices.
Inogen, Inc. is a medical device company focusing on innovation in oxygen therapy. As a focused innovator, manufacturer, and provider of long term oxygen therapy, Inogen’s business model aims to increase patient satisfaction, reduce cost, and lessen the burden on the overall healthcare system. As a fully integrated home healthcare provider, Inogen manufactures and deploys oxygen therapy products directly to the patients that it serves. Inogen’s key product offering is the Inogen One line of compact, quiet and easily portable oxygen concentrators – devices that extract oxygen out of room air to eliminate the burden of cumbersome oxygen tanks.
Juliet Marine Systems, Inc. is a maritime technology think tank that is developing innovative solutions for naval and commercial applications. The Company seeks to assure fleet force protection in response to small vessel terrorist attacks against the U.S. Navy and coalition ships.
The GHOST is a surface vessel; the hydrodynamics of the twin submerged buoyant tubular foils are also a test bed for Juliet Marine’s next planned prototype, a long duration UUV (Unmanned Undersea Vessel). The GHOST is a revolutionary proprietary technology vessel platform that will assure force protection through stealth fighter/attack capabilities along with integrated situation awareness. These vessels would create a protective fleet perimeter, providing sensor and weapons platforms, allowing no surface or subsurface intrusions. The GHOST is two to three times as fast as most ferries in use today.
Kaltura provides the world’s first Open Source Online Video Platform, transforming the way people work, learn and entertain, using video. Kaltura’s platform engages hundreds of millions of viewers, offers next generation learning for millions of students and teachers, and improves productivity and interaction among millions of employees across the globe. Kaltura’s features and products enable organizations to easily deploy video in any website or any web platform.
Kinvey, Inc. is a mobile cloud backend as a service provider. Kinvey is a Backend as a Service (“BAAS”) platform that makes it easy for developers to set up and operate backends for their mobile, tablet and Web apps. Using Kinvey developers simply code their app using any Software Developer’s Kit of their choice. The Kinvey backend middleware and data layers sit across multiple cloud service providers (e.g. Rackspace, Amazon EC2 and Microsoft Azure.) The company has close to 1,600 developers using its service and recently launched the commercial beta version of the product.
Korrelate, Inc. formerly known as adsummos was founded in January 2010 by three members of the senior management team of TACODA: the former CEO, the former CTO and the former head of Revenue Operations. TACODA was a pioneer in behaviorally-targeted advertising and was sold to AOL in September 2007. Korrelate’s original business model incorporated partnering with premium web publishers to recapture higher cost per thousand impressions (CPMs) on their sites by offering precision targeted ads at scale to leading brand advertisers. The Company recently sold its real time bidding (RTB) platform to operative and is now focused on correlating online media spending to offline purchases in a privacy-safe manner. Its online-to-offline (O2O) solution allows marketers to directly connect their digital marketing spend to consumers who purchase their products offline. For the first time marketers will know if their digital investment is driving real sales.
Memrise, Inc. brings together the most powerful ideas from the science and practice of learning with game dynamics to help people learn in the quickest and most enjoyable way possible. Memrise was founded by Greg Detre, who has a Ph.D. in neuroscience, and Ed Cooke, the Memory Grandmaster who taught the journalist Josh Foer to win the U.S. Memory Championship in one year.
MOGL is the game that pays you cash for eating at your favorite restaurant. MOGL is a spin-out of Mojo Pages.
Nanigans offers a fully automated Facebook advertising solution. The Nanigans product, Ad Engine, automates the labor-intensive process of managing large-scale Facebook ad campaigns. Nanigans drives tens of billions of social ad impressions each month for over 200 companies. Founded by veteran entrepreneurs from the ad space, Nanigans was formed to help advertisers maximize the effectiveness of Facebook advertising.
Ortiva Wireless, Inc. provides software to wireless carriers that enable them to deliver the smoothest video, clearest audio, and richest multimedia experience to mobile users under highly variable wireless network conditions. Ortiva’s Mobile Content Delivery Network (Mobile-CDN™), extends carriers’ coverage and expands the availability of rich media content.
Otonomy is a clinical stage biopharmaceutical company developing novel drug therapies for disorders of the inner and middle ear. This field represents a large opportunity as there are no approved drug treatments for the nearly 30 million Americans facing debilitating hearing and balance disorders such as Ménière’s disease, sudden sensorineural hearing loss, noise-induced hearing loss, age-related hearing impairment, and tinnitus. Additionally, new therapies are required for otitis media since resistance to oral antibiotics is increasing and short-acting locally administered drugs present significant compliance challenges. Otonomy is working in partnership with leading experts in the field of otology to bring new drug therapies to patients suffering with these conditions.
Panmira is the Amira pre-acquisition spin-out of the DP2 asset. Panmira formally started business at the beginning of September after splitting from Amira at the time of Amira’s acquisition by Bristol Myers Squibb. The company was provided with $5M from Amira to fund its operations. The company had eight employees at the inception.
Panmira’s mission was to partner the assets that it acquired from Amira namely the CRTH2 program (containing two clinical phase compounds; AM211 and AM461), a FLAP compound for topical use (AM679) and a preclinical lead for 5-LO. Panmira downsized the operations to three employees and out-sourced all other activities.
Relentlessly Innovative. Pictela is revolutionizing how brand content is created, distributed and measured.
Pictela is a dynamic, high definition brand content platform. The platform delivers video, photos and applications in real time across the web.
Pictela was acquired by AOL.
PingUp is a service that replaces the phone conversation with a universal chat utility that allows consumers to send text messages to businesses and the business to reply by text message in real-time. Many people (especially the younger generation) have come to prefer text messages over voice calls for those short, simple conversations such as making inquiries or reservations.
Proximal Data is the leading provider of server-side caching solutions specifically designed for virtualized environments. Proximal Data’s AutoCache™ software can dramatically increase virtual machine density by eliminating I/O bottlenecks with adaptive I/O caching. When coupled with PCIe flash cards or SSDs from our partners, Proximal Data’s fast virtual cache significantly improves the efficiency and performance of virtualized servers without disrupting IT operations or processes.
RethinkDB is a seed stage company developing non-SQL database software intelligently designed to benefit from solid–state disks and persistent RAM memory storage. The goal of ReThink DB is to offer commercial non-SQL compatible software designed to be extremely fast through the implementation of powerful features that are cumbersome and inefficient with rotational storage. Database software today is optimized for the latency inherent in rotational media. ReThink DB takes full advantage of solid-state drives, and persistent RAM making traditional data storage layouts unnecessary. The short-term goal of ReThink DB is to be the database of the future, today. As data centers switch to the next generation of disk drives, solid-state drives, and persistent RAM, ReThink DB intends to let customers take advantage of the new RAM and disk architecture and benefit from the vastly increased access speeds and concurrency to achieve vast performance improvements over existing database architectures.
RQx Pharmaceuticals, Inc. is a biopharmaceutical company developing broad spectrum antibiotics. The Company endeavors to optimize natural product chemical scaffolds using medicinal chemistry techniques to generate broad spectrum antibiotics. RQx is focused on a novel molecular target for which no antibiotic has been developed. Additionally, RQx has generated proprietary molecules based on a novel chemical scaffold. RQx and its technologies are a strong response to the world’s growing need for new antibiotics (due to resistance) and the lack of success with small molecules over the past 20 years. The Company’s initial products will focus on community and hospital associated infections, including those from gram-negative bacteria. The Company was founded based on important discoveries in Floyd Romesberg’s lab at the The Scripps Research Institute in La Jolla, CA.
ScoreStream is an application and utility that allows fans to share information with others around sporting events. The Company found it increasingly difficult to find information on local sports teams such as hometown high schools, and also felt constrained by the minimal nature of text messaging when sharing moments in kids’ sports with friends and family. ScoreStream’s mobile application lets users share rich information about local teams with others in a simple and straightforward manner.
Selectable Media enables consumers to unlock digital content through video advertising. Selectable’s platform delivers highly engaged audiences for brand marketers across online, mobile and tablet devices.
Shelby.tv is the best way to discover and consume video. Online video is proliferating across our phones, tablets, PC’s, and TV’s, and Shelby gives a singular place to watch with a stream of video inspired by your friends and backed up by big data.
Simulmedia is a media/marketing company dedicated to improving the effectiveness of program promotion on television. The Company is pioneering the use of sophisticated data analysis and predictive technology to help television companies deliver the right on-air promotions to the right viewers at the right time and build the world’s first full-scaled digital ad targeting platform for linear television. Simulmedia’s unwired audience network reaches all 116 million U.S. TV homes in partnership with seven of the eight largest system operators and more than 30 television networks.
Sova Pharmaceuticals, Inc. is a discovery stage company seeking to make therapeutics to treat central sleep apnea.
Stack IQ develops and sells Rocks+, a multi-server management system for clusters and clouds. Rocks+ provides a single step install and single point of management for Linux environments – and is capable of dynamically provisioning heterogeneous server types by leveraging pre-packaged “Rolls” and user-defined appliance types.
![stackiq-logo[1]](http://www.avalon-ventures.com/wordpress/wp-content/uploads/2011/05/stackiq-logo14-250x63.jpg "stackiq-logo[1]"){kind=logo}
Standing Cloud, Inc. is a leading provider of cloud application management services. The Company provides a seamless application layer for cloud service providers, and a cloud management platform for independent software vendors. The service makes application deployment and management fast, simple and hassle-free for end customers.
TechStars is an elite, mentorship-driven, start-up accelerator and seed fund. Founded in 2006 and recently recognized as the number one accelerator program, the TechStars philosophy focuses on deep mentorship and surrounding a small number of companies with highly engaged members of the entrepreneurial ecosystem to coach and support them to success. The TechStars community currently includes more than 300 mentors, more than 1,000 investors, and 120 alumni TechStars companies. TechStars currently operates six programs each year: Boulder, Boston, Seattle, New York, and most recently, TechStars Cloud. TechStars is funded by more than 50 venture capital firms, and more than 25 angel investors. Companies that are accepted into the program get unequaled mentorship, $18K in funding, and amazing perks in exchange for 6% common/founders stock. Recently, TechStars announced an optional and additional $100K in funding to teams.
Syndax Pharmaceuticals is a late-stage clinical development oncology company with a platform based on an epigenetic approach to overcoming the problem of resistance in cancer therapy. Syndax holds worldwide rights to entinostat, an oral, highly selective, class I histone deacetylase (HDAC) inhibitor, which inhibits cancer-relevant HDAC enzymes that contribute to epigenetic alterations driving cancer growth and drug tolerance. Targeted therapies represent an important class of agents used to treat both breast and lung cancers based on blocking the tumor’s addiction to growth promoting signals. Over time these therapies become ineffective due to acquired resistance. There are more than 300,000 individuals living with incurable breast or lung cancer in the United States. Entinostat’s unique pharmacokinetic properties, convenient oral dosing and HDAC selectivity, maximize the potential to safely combine with and extend the benefit of proven cancer targeted therapies. Syndax has a robust clinical program exploring the potential for entinostat to treat breast and lung cancer and additional types of cancer through collaboration with the National Cancer Institute.
Tapad, Inc. is an advertising technology company leading the way in smart device advertising. The Company’s technology allows marketers and advertisers to make real-time decisions about the value of a user before serving an ad. Tapad’s cloud-based, open platform is scalable to billions of ad impressions per day, and provides unprecedented transparency and flexibility when buying mobile ads. Using Tapad’s proprietary ad platform, advertisers can now engage the same consumer with consistent ads across multiple platforms ranging from PCs to tablets to Smartphones. This unified view of the consumer allows advertisers to target, and retarget, consumers based on location and audience segments.
TwinStrata is an innovator in data storage, data protection and disaster recovery solutions using cloud storage. CloudArray® iSCSI storage gateway makes cloud storage as fast, safe and easy to use as local storage. Both CloudArray virtual and physical appliances configure in minutes and integrate public cloud, private cloud and existing storage devices into flexible “Cloud SANs” that provide unlimited storage capacity, without the capital and maintenance expenses of traditional storage. TwinStrata offers its products through a network of IT service providers, systems integrators, OEMs and direct-to-end users.
Uwanna, Inc. is an advertising platform integrated with social media networks such as Google+ and Facebook that delivers real-time, hyper-local offers to consumers as they’re planning activities. Friends invite each other to join in genuinely social activities and the proprietary Uwanna algorithm matches local offers to their events.
Uwanna is creating the first free and open-sourced offer-and-deal service that enables businesses to promote sustainable offers affordably and easily. Consumers interact with Uwanna via the mobile application, the Uwanna.com website, and the Uwanna Facebook application.
Businesses and brands, from local coffee shops to multi-national advertisers, deliver their offers via these services as well as through their own websites and banner advertising. The platform is also available for media companies to promote social activities around their content and enhance the value of their advertising inventory.
In addition to the Company’s consumer facing applications, Uwanna is developing a set of APIs so that the new third-party group messaging services (which are rapidly displacing carrier-based SMS clients) can integrate the offer platform and accelerate distribution of the Uwanna platform.
Vocera Communications, Inc. provides wireless communication systems enabling instant voice communication among mobile workers for leading institutions and companies requiring enhanced customer service, productivity, and teamwork.
Zacharon Pharmaceuticals, Inc. is leveraging unique glycobiology expertise to develop an entirely new class of human therapeutics targeting glycans, the carbohydrate portions of glycoproteins, proteoglycans, and glycolipids. Glycans provide attractive targets for a variety of human diseases including lysosomal storage diseases, oncology, inflammation, and others. To unlock this potential, Zacharon created an innovative glycan-targeted drug development platform, a technology breakthrough enabling a new class of human therapeutics addressing substantial unmet needs.
Zynga is the # 1 social gaming company on the web. Zynga was founded on the notion that casual games are far more fun, interesting and compelling when you can play with your friends. Zynga’s games run inside social networks and mobile platforms and take advantage of the pre-existing social graphs. Zynga was founded by Mark Pincus and is based in San Francisco.
